Coagadex® (coagulation Factor X [human]) – New and expanded indications
September 21, 2018 - The FDA approved Bio Products Laboratory’s Coagadex (coagulation factor X [human]), in adults and children with hereditary Factor X deficiency, for on-demand treatment and control of bleeding episodes, perioperative management of bleeding in patients with mild and moderate hereditary Factor X deficiency, and for routine prophylaxis to reduce the frequency of bleeding episodes.
Top